Cell Surgical Network Corporation

Rancho Mirage, CA · Biotech · Private

Autologous adipose-derived stromal vascular fraction (SVF) for treating blast traumatic brain injury and PTSD symptoms

Claim this profile

Follows are private to you and power your alerts

Updated · stemcellrevolution.com

Sector
Biotech
Headquarters
Rancho Mirage, CA
Total capital
$1.2M
Federal grants
$800K
2 awards · 2019–2022
Rank in peer group#61 of 502
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
$413K
1 award · Defense
Rank in Biotech#239 of 4373
Granted patents
1
2 pending · first 2023
Rank in peer group#57 of 502

Capital timeline

2019202020212022FEDERAL ↑EQUITY ↓Cumulative $1.2M$50K$413K$750K
2019202020212022FEDERAL ↑EQUITY ↓Cumulative $1.2M$50K$413K$750K

Latest events

  • Federal grantDefense · Phase II · Efficacy and Safety of Fresh SVF For Combat Veterans with PTSD and Blast Trauma Exposure$750K
  • Federal contractDefense · Efficacy And Safety Of Fresh Stromal Vascular Fraction For Combat Veterans With Post Traumatic Stress Disorder (ptsd) And Blast Trauma Exposure$413K
  • Federal grantDefense · Phase I · Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need$50K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 502 peers

Line = median

Biotech · Molecule

  • Federal grants#61 · top 12%
  • Granted patents#57 · top 11%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 3

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .